AEON Biopharma Inc

AEON Biopharma names John Bencich CFO to strengthen financial governance and fuel its neurotoxin‑based pipeline, positioning the company for future growth and capital‑raising success.

AEON Biopharma pivots from neuro‑toxin research to AI‑driven crypto payments, sparking investor debate on whether its biotech roots can fuel a fintech future.

AEON Biopharma Inc. is a clinical-stage biopharmaceutical company that has recently expanded into crypto payments and launched a humanoid robot, AEON, for industrial applications.